Ranbaxy Laboratories reports consolidated net loss of Rs 492.44 crore in Q4

26 Feb 2013 Evaluate

Ranbaxy Laboratories has reported results for fourth quarter and year ended December 31, 2012.

The company has reported a net loss of Rs 616.09 crore for the quarter ended December 31, 2012 as compared to a net loss of Rs 2710.32 crore for the same quarter in the previous year. Total income of the company has decreased by 61.61% at Rs 1508.63 crore for quarter under review as compared to Rs 3930.35 crore for the quarter ended December 31, 2011.

On consolidated basis, the company has reported a net loss of Rs 492.44 crore for the quarter ended December 31, 2012 as compared to a net loss of Rs 2982.76 crore for the same quarter in the previous year. Total income of the company has decreased by 27.95% at Rs 2787.88 crore for quarter under review as compared to Rs 3869.38 crore for the quarter ended December 31, 2011.

For the fiscal 2012, the company has reported a net loss of Rs 162.33 crore for the year ended December 31, 2012 as compared to a net loss of Rs 3052.04 crore for the same in the previous year. Total income from operations went down by 16.38% to Rs 6543.14 crore from Rs 7825.19 crore in last year.

For the entire fiscal, on consolidated basis the company has reported a net profit of Rs 922.76 crore for the year ended December 31, 2012 as compared to a net loss of Rs 2899.72 crore for the same in the previous year. Total consolidated income from operations went up by 22.74% to Rs 12732.89 crore from Rs 10373.92 crore in last year.

Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×